Prognostic value of test(s) for O 6 -methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide (2019)

First Author: McAleenan A
Attributed to:  Fuse, the Centre for Translational Reseach in Public Health (renewal) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/14651858.cd013316

Publication URI: http://dx.doi.org/10.1002/14651858.cd013316

Type: Journal Article/Review

Parent Publication: Cochrane Database of Systematic Reviews